To confirm that NEO-201 binds specifically to cancer cells expressing tumor-associated variants of CEACAM-5 and CEACAM-6, which are not expressed in normal tissues, we used human tissue microarrays of various cancer types for immunohistochemistry analysis. Here, CEACAM5 is linked to cancer.